First Ever ALS Breakthrough!
INCELL Pioneering the World’s First Effective Cell Therapy for ALS
For Immediate Release July 25, 2024
(San Antonio, Texas). ALS, or amyotrophic lateral sclerosis, is defined by the ALS Association (als.org) as a
progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. ALS symptoms vary
and patients may lose the ability to speak, eat, move and breathe. There is no cure. The Mayo Clinic reports
(mayoclinic.org) that no treatments can reverse ALS damage, but they may slow the progression of disease
symptoms or help prevent complications. INCELL is committed to tackling innovative ALS therapy.
October 27, 2016 – San Antonio, TX USA. INCELL and the BIOTURNKEY Initiative, our joint venture partner in Belgium, will co-sponsor a booth at the 12th Annual World Stem Cell Summit in West Palm Beach, FL on December 6-9, 2016. This kicks off a new initiative on accelerating GMP and closed system manufacturing. Visit us at Booth 203 to learn how we can help you meet your manufacturing needs. Register for the meeting at 
March 14-16, 2016 – San Antonio, TX USA. INCELL is a Sponsor of the 2016 national Parenteral Drug Association (PDA) meeting. INCELL will have a trade show booth with manufacturing and project managers on site to discuss manufacturing sterile fill and other products. INCELL scientists, Dr. Mary Pat Moyer, Vanessa Ramirez and George Plasko will participate in the 3-day event, discussions, networking and business development.
April 7-9, 2016 – Austin, TX USA. Dr. Mary Pat Moyer, INCELL CEO and Chief Science Officer, is an invited member of the National Visiting Committee for the National Science Foundation (NSF)-supported Bio-Link Regional Center and biotechnology training program at Austin Community College . 
January 12, 2016 – San Antonio, TX USA. INCELL hosted international visitors for presentation, tour and discussions. INCELL was selected by Global Strategic Partnerships as a visit site representing a “best-in-class, organically grown” US-based life sciences company for the Innovation, Investment and Economic Development Program for 32 international Bentley University faculty and MBA students. The 2016 visitors were from many countries: Bulgaria, Egypt, India, Nigeria, Peru, Philippines, Poland, Romania, Russian Federation, Saudi Arabia, Serbia, Spain, Venezuela, and the United States.
April 15, 2016 – Dallas TX, USA. The FDA Medical Device Industry Coalition (FMDIC) is sponsoring its 2016 Big Event on the topic “Quality System Survival: Success Strategies for P&PC/CAPA.” 
September 12-13, 2016 – Washington DC, USA. Dr. Mary Pat Moyer, INCELL CEO and Chief Science Officer, has been selected to speak in Session 1 at the US Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Public Hearing on Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products.
March 7, 2016 – San Antonio, TX USA. The Leadership Texas Class of 2016 has selected Dr. Mary Pat Moyer to be their honored guest at a recognition dinner as a “Luminary Woman of San Antonio.” Leadership Texas is highly competitive and the longest-running women’s leadership development program in the US. It is designed specifically to help women learn about critical issues outside of their own industries and spheres of influence. Dr. Moyer is a graduate of the class of 1992, and the experiences with her Leadership Texas class had a positive impact on her decision to found INCELL as a new biotechnology company in 1993. Leadership Women: Proudly presenting Leadership Texas since 1983.